Diabetes Obes Metab 19(3):33647 Buse JB, Klonoff DC, Nielsen LL, Guan X, Bowlus CL, Holcombe JH et al (2007) Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials
doi:10.1016/s0304-4165(01)00127-1
Prep the vial Prep the vial Let the vial reach room temperature, wipe the rubber top with an alcohol swab, and check that the liquid is clear
Dealing with dead space in syringes Every syringe has a small amount of "dead space" in the hub where the needle attaches to the barrel
Everyone starts at 2.5 mg once weekly regardless of body weight, previous medication use, or weight loss goals
Our platform represents the merger of cutting-edge telehealth with personalized, medically supervised care, all designed to make sustainable weight loss attainable and tailored to you